We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

1 hedge funds and large institutions have $76K invested in Dicerna Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $73K | Put options by funds: $20K

99% less funds holding

Funds holding: 173 → 1 (-172)

100% less capital invested

Capital invested by funds: $1.25B → $76K (-$1.25B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
$73K
Puts
$20K
Net Calls
+$53K
Net Calls Change
-$10.6M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$153M
2
BlackRock
BlackRock
New York
-$116M
3
State Street
State Street
Massachusetts
-$78.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$74.7M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$62.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
76
Parametric Portfolio Associates
Washington
– -$1.53M -76,037 Closed
TD Asset Management
77
TD Asset Management
Ontario, Canada
– -$1.5M -74,186 Closed
CS
78
Credit Suisse
Switzerland
– -$1.49M -73,902 Closed
AAM
79
Advisors Asset Management
Colorado
– -$1.41M -70,029 Closed
Bank of Montreal
80
Bank of Montreal
Ontario, Canada
– -$1.41M -69,978 Closed
MCM
81
Manchester Capital Management
Vermont
– -$1.32M -65,742 Closed
Legal & General Group
82
Legal & General Group
United Kingdom
– -$1.22M -60,386 Closed
CSS
83
Cubist Systematic Strategies
Connecticut
– -$1.19M -58,993 Closed
Victory Capital Management
84
Victory Capital Management
Texas
– -$1.12M -55,337 Closed
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
– -$1M -49,739 Closed
Deutsche Bank
86
Deutsche Bank
Germany
– -$988K -49,026 Closed
SG Americas Securities
87
SG Americas Securities
New York
– -$896K -44,429 Closed
Barclays
88
Barclays
United Kingdom
– -$852K -42,226 Closed
Capital Fund Management (CFM)
89
Capital Fund Management (CFM)
France
– -$807K -40,044 Closed
ECM
90
ExodusPoint Capital Management
New York
– -$795K -39,453 Closed
AIG
91
American International Group
New York
– -$768K -38,094 Closed
PP
92
PDT Partners
New York
– -$755K -37,460 Closed
CM
93
Caption Management
Oklahoma
– -$755K -37,443 Closed
KOCAA
94
Knights of Columbus Asset Advisors
Connecticut
– -$745K -36,962 Closed
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$734K -36,401 Closed
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
– -$707K -35,076 Closed
SO
97
STRS Ohio
Ohio
– -$649K -32,200 Closed
SCM
98
Silverarc Capital Management
Massachusetts
– -$626K -31,040 Closed
WG
99
Winton Group
United Kingdom
– -$615K -30,485 Closed
Principal Financial Group
100
Principal Financial Group
Iowa
– -$600K -29,760 Closed
2 3
4
5 6

DRNA Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2021, worth a combined $76K — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of DRNA and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $153M sold.

  • 1 institutional investor held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2021, down from 173 in Q3 2021.
  • Funds reported $76K of Dicerna Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2021 and 170 closed out, a net change of -170 holders.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2021 was RTW Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q4 2021.